Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
CAS RN: 50700-72-6 | Product Number: V0120
Vecuronium Bromide
Purity: >98.0%(T)(HPLC)
- 1-[(2β,3α,5α,16β,17β)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
100MG |
€67.00
|
1 | ≥40 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Supplemental Product Information:
Previously this product had been labeled as a hydrate form both in product name and molecular formula. The hydrate form had no exclusive CAS RN and used to share the same CAS RN as the anhydrous form.
To avoid any misleading information and since moisture in product is considered as an impurity, we have decided to remove the term 'Hydrate' from product name and 'xH2O' from the molecular formula for such products.
Please use it at ease since there is no difference in product quality, even if you see the previous indications on a part of label.
Product Number | V0120 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__3__4H__5__7BrN__2O__4 = 637.74 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 50700-72-6 |
Reaxys Registry Number | 4106207 |
PubChem Substance ID | 253660212 |
Merck Index (14) | 9941 |
MDL Number | MFCD00867762 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 %(calcd.on anh.substance) |
Specific rotation [a]20/D | +31.0 to +34.0 deg(C=1, 0.05mol/L HCl) |
Water | max. 4.0 % |
NMR | confirm to structure |
Melting Point | 235 °C(dec.) |
Specific Rotation | 32° (C=1,0.05mol/L HCl) |
Solubility (insoluble in) | Ether |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
EC Number | 256-723-9 |
RTECS# | TN4875000 |
HS Number | 2933399990 |
References
- Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat
- Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals
- The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms
- Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium
- The potency of new muscle relaxants on recombinant muscle-type acetylcholine receptors
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.